Gonorrhea cases have surged among young women in 15 European countries in 2022 and 2023, with a less significant increase observed among young men, highlighting
WASHINGTON — The Biotechnology Innovation Organization, an industry trade group, is cutting ties with Chinese company WuXi in response to increasing U.S. government scrutiny of
Speaking before a virtual audience of CommonSpirit Health employees, RaDonda Vaught, the former nurse who accidentally killed a patient by administering the wrong medication, listed
A series of new studies are raising hopes that CAR-T, a process in which treatments are made by genetically editing a patient’s own white blood
Doctors have been eagerly waiting for data on Guardant Health’s new blood-based colorectal cancer screening test, the Shield test. The hope has been that Guardant
TORONTO–(BUSINESS WIRE)–Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation
Toronto, Ontario–(Newsfile Corp. – March 13, 2024) – PharmaDrug Inc. (CSE: PHRX) (OTC PINK: LMLLF) (“PharmaDrug” or the “Company“), a specialty pharmaceutical company focused on
In a groundbreaking move, the Multidisciplinary Association for Psychedelic Studies (MAPS) has joined forces with Denver, marking a historic collaboration aimed at revolutionizing emergency response
VANCOUVER, BC, March 12, 2024 /CNW/ – Numinus Wellness Inc. (“Numinus” or the “Company“) (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative behavioral health treatments
Vancouver, Canada, March 13, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the “company”), a biotech company focused on